Trident Lifeline Limited

543616

INE0MKA01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-16 am EDT			5-day change	1st Jan Change
314.6 ^INR	+4.88%		+3.95%	+67.37%

May. 17	Trident Lifeline's CFO Resigns	MT
May. 16	Trident Lifeline Limited Announces Resignation of Mayurkumar Mansukhbhai Gajera as Chief Financial Officer	CI

Trident Lifeline Limited Announces Resignation of Jiteshkumar R Varkal as Company Secretary & Compliance Officer

May 01, 2024 at 08:35 am EDT

Trident Lifeline Limited announced that Mr. Jiteshkumar R Varkal has tendered his resignation from the post of Company Secretary & Compliance Officer of the Company with effect from 30th May, 2024.

Latest news about Trident Lifeline Limited

Trident Lifeline's CFO Resigns	May. 16	MT
Trident Lifeline Limited Announces Resignation of Mayurkumar Mansukhbhai Gajera as Chief Financial Officer	May. 16	CI
Trident Lifeline Limited Announces Resignation of Mayurkumar Mansukhbhai Gajera as Whole Time Director and Member of the Audit Committee	May. 16	CI
Trident Lifeline Limited Announces Resignation of Jiteshkumar R Varkal as Company Secretary & Compliance Officer	May. 01	CI
Trident Lifeline Limited Announces Board and Committee Changes	Apr. 27	CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Apr. 27	CI
Trident Lifeline Commissions Manufacturing Units in Surat, India	Apr. 26	MT
Trident Lifeline Incorporates Wholly Owned Arm	Apr. 15	MT
Trident Lifeline Limited Approves the Proposal of Incorporation of A Wholly Owned Subsidiary	Apr. 06	CI
Trident Lifeline Limited Announces Appointment of Jiteshkumar Ramchandra Varkal as Company Secretary and Compliance Officer	Dec. 11	CI
Trident Lifeline Limited Announces Resignation of Kunal Amrishbhai Chauhan from the Post of Company Secretary and Compliance Officer	Nov. 30	CI
Trident Lifeline Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 04	CI
5,649,460 Equity Shares of Trident Lifeline Limited are subject to a Lock-Up Agreement Ending on 16-OCT-2023.	23-10-15	CI
Trident Lifeline Completes Acquisition of 51% Stake in TLL Herbal	23-08-10	MT
Trident Lifeline Limited completed the acquisition of TLL Herbal Limited.	23-08-09	CI
Trident Lifeline Limited completed the acquisition of 18% stake in Tricorp Industries Limited.	23-07-24	CI
Trident Lifeline to Acquire 18% Stake in Indian Chemicals Manufactuer	23-07-20	MT
Trident Lifeline Limited agreed to acquire 18% stake in Tricorp Industries Limited for INR 0.18 million.	23-07-19	CI
Trident Lifeline Gets Board Nod to Acquire Majority Stake in TLL Herbal	23-07-16	MT
Trident Lifeline Limited Announces the Resignation of Mr. Dhavl V Shah as Independent Director	23-07-15	CI
Trident Lifeline Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-15	CI
Trident Lifeline Limited agreed to acquire 51% stake in Tll Herbal Limited from existing shareholders for INR 0.51 million.	23-07-14	CI
Trident Lifeline Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-06	CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-06	CI
Trident Lifeline Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-16	CI

Chart Trident Lifeline Limited

Duration

Period

More charts

Trident Lifeline Limited is an India-based pharmaceutical company, which is engaged in providing of capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. The Company operates through seven geographical segments: India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, Rest of World. The Company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, Non-Steroidal Anti-Inflammatory Drug (NSAIDS).

Sector

Pharmaceuticals

Calendar

2024-11-10 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TRIDENT LIFELINE LIMITED	+67.37%	41.28M
ELI LILLY AND COMPANY	+63.05%	856B
NOVO NORDISK A/S	+38.91%	631B
JOHNSON & JOHNSON	-4.78%	359B
MERCK & CO., INC.	+17.52%	325B
ABBVIE INC.	+8.43%	297B
ASTRAZENECA PLC	+13.60%	244B
ROCHE HOLDING AG	+5.03%	234B
NOVARTIS AG	+16.30%	226B
AMGEN INC.	+14.63%	177B